345 related articles for article (PubMed ID: 11375625)
21. Breast and ovarian cancer genetics and prevention.
Altaha R; Reed E; Abraham J
W V Med J; 2003; 99(5):187-91. PubMed ID: 14959510
[TBL] [Abstract][Full Text] [Related]
22. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
[TBL] [Abstract][Full Text] [Related]
23. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
Hamann U
Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
[TBL] [Abstract][Full Text] [Related]
24. [Clinical counseling and care of women with genetic predisposition to breast and ovarian carcinoma].
Schmutzler RK; Kempe A; Kiechle M; Beckmann MW
Dtsch Med Wochenschr; 1999 May; 124(18):563-6. PubMed ID: 10356583
[No Abstract] [Full Text] [Related]
25. Breast cancer genetics: what we know and what we need.
Nathanson KL; Wooster R; Weber BL
Nat Med; 2001 May; 7(5):552-6. PubMed ID: 11329055
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor genes and breast cancer.
Buchholz TA; Weil MM; Story MD; Strom EA; Brock WA; McNeese MD
Radiat Oncol Investig; 1999; 7(2):55-65. PubMed ID: 10333246
[TBL] [Abstract][Full Text] [Related]
27. Genetic testing for cancer: a complex decision.
Harv Womens Health Watch; 2001 Feb; 8(6):2-4. PubMed ID: 11175466
[No Abstract] [Full Text] [Related]
28. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
29. [Clinical and molecular diagnosis of inherited breast-ovarian cancer].
Chompret A
J Gynecol Obstet Biol Reprod (Paris); 2003 Apr; 32(2):101-19. PubMed ID: 12717301
[TBL] [Abstract][Full Text] [Related]
30. [Update on genetic markers of cancer].
Janoueix-Lerosey I; Delattre O
Bull Cancer; 1999 Jan; 86(1):15-21. PubMed ID: 10029699
[No Abstract] [Full Text] [Related]
31. BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women.
Gilbert F; Dabney MK; Diemer K; Ludwig S; Rosenthal G; Osborne MP
Ann N Y Acad Sci; 1997 Dec; 833():198-203. PubMed ID: 9616755
[No Abstract] [Full Text] [Related]
32. Are local recurrences after breast conserving therapy more frequent in patients with BRCA1/BRCA2 mutations?
Kurtz JM
Strahlenther Onkol; 2000 Sep; 176(9):433-4. PubMed ID: 11050918
[No Abstract] [Full Text] [Related]
33. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
[TBL] [Abstract][Full Text] [Related]
34. Sex steroid hormones and genetic susceptibility to breast and prostate cancer.
Feigelson HS; Ross RK; Yu MC; Coetzee GA; Reichardt JK; Henderson BE
Drug Metab Rev; 1998 May; 30(2):421-34. PubMed ID: 9606611
[No Abstract] [Full Text] [Related]
35. A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.
Wang WW; Spurdle AB; Kolachana P; Bove B; Modan B; Ebbers SM; Suthers G; Tucker MA; Kaufman DJ; Doody MM; Tarone RE; Daly M; Levavi H; Pierce H; Chetrit A; Yechezkel GH; Chenevix-Trench G; Offit K; Godwin AK; Struewing JP
Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):955-60. PubMed ID: 11535547
[TBL] [Abstract][Full Text] [Related]
36. Genetic testings for cancer: the surgeon's critical role. Familial breast cancer.
Weber BL
J Am Coll Surg; 1999 Jan; 188(1):79-86. PubMed ID: 9915248
[No Abstract] [Full Text] [Related]
37. [From gene to disease; from BRCA1 OR BRCA2 to breast cancer].
Van den Ouweland AM
Ned Tijdschr Geneeskd; 2001 Jun; 145(25):1228. PubMed ID: 11447881
[No Abstract] [Full Text] [Related]
38. Psychological impact of receiving a BRCA1/BRCA2 test result.
Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF
Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450
[TBL] [Abstract][Full Text] [Related]
39. Genetic tests forge ahead, despite scientific concerns.
Marshall A
Nat Biotechnol; 1996 Dec; 14(13):1642-3. PubMed ID: 9634835
[No Abstract] [Full Text] [Related]
40. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
